skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration
  • Close Icon

Zach McLellan, Jack Allen and this weeks guest analyst Dan Chancellor discuss current events in the healthcare space in the Datamonitor Healthcare Analyst Podcast.

Topics covered in this episode include:

  • Analysis of the Sangamo Therapeutics and Gilead/Kite partnership for allogeneic oncology products (SGMO GILD CLLS CRSP NTLA EDIT) - 0:49
  • Celgene receives RTF letter from FDA with respect to ozanimod in MS (CELG NVS)- 14:12
  • Update on Restasis patent disputes (AGN) - 31:50
  • Earnings takeaways – PARP overview and Portola FDA communication surrounding the need for a randomized clinical trial of AndexXa (AZN TSRO CLVS PTLA) - 36:30

Subscribe to this podcast here